Page last updated: 2024-09-03

bay x 1005 and allopurinol

bay x 1005 has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(bay x 1005)
Trials
(bay x 1005)
Recent Studies (post-2010)
(bay x 1005)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
586815,0967433,363

Protein Interaction Comparison

ProteinTaxonomybay x 1005 (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fruchtmann, R; Fugmann, B; Hatzelmann, A; Horstmann, H; Junge, B; Mohrs, KH; Müller-Peddinghaus, R; Raddatz, S1

Other Studies

1 other study(ies) available for bay x 1005 and allopurinol

ArticleYear
In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis.
    Agents and actions, 1993, Volume: 38, Issue:3-4

    Topics: Animals; Arachidonic Acid; Calcimycin; Cells, Cultured; Humans; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Methemoglobin; Mice; Mice, Inbred BALB C; Neutrophils; Quinolines; Rats; Rats, Wistar; Reactive Oxygen Species; Stereoisomerism; Xanthine Oxidase; Zymosan

1993